Director, US Real-World Evidence & Health Outcomes -Multiple Myeloma
GSK
August 06, 2026
Remote friendly (Durham, NC)
United States
Market Access
Responsibilities:
- Evidence strategy and planning: Develop US RWE/HO evidence generation plan and design multiple studies aligned to US medical, payer, and access needs; translate strategy into workplans, timelines, and resourcing; develop study concepts, protocols, and innovative, cost-effective study approaches.
- Study leadership (RWE/HEOR): Lead day-to-day real-world evidence and health outcomes studies (e.g., RWE studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, patient-focused outcomes) with internal teams and external vendors.
- Stakeholder management: Provide periodic reporting to TA aligned business leaders; lead cross-functional meetings to align on evidence gaps and priorities; build relationships across Medical, Market Access, R&D, and Commercial.
- Scientific communication and quality: Draft/review specifications, protocols, statistical analysis plans, reports, abstracts, posters, manuscripts; ensure SOP adherence and high scientific/operational quality.
- Internal decision support: Provide RWE/HO input for development and commercialization planning (trial design, data gap assessments, value messages, evidence prioritization).
- External insight generation: Partner with Field Based Payer Medical Teams and field stakeholders; incorporate insights into evidence plans.
- Vendor and budget management: Manage scope, timelines, budgets, and change control; proactively escalate risks/issues.
- Governance/compliance/capability building: Complete required training and adhere to SOPs; improve processes for RWE/HO deliverables.
Required qualifications:
- Master’s or PhD in health economics/outcomes research, epidemiology, public health, biostatistics, or related.
- 3+ years pharma industry or academia research with US Oncology experience.
- Publication plan experience; RWE/HO study presence at major clinical congresses.
- Experience managing multiple projects simultaneously.
- Expertise in RWE and economic evaluation methods (publications; concept sheets/protocol contributions; bias/confounding mitigation; SAP/report contributions; publication/disclosure readiness).
- Strong communication/presentation skills.
- Proven ability to prioritize and manage in a matrix environment.
Preferred qualifications:
- Demonstrated success delivering health outcomes research outputs.
- Oncology experience (US/global) and familiarity with evolving standards/evidence needs.
- Advanced experience (Master’s 4–6 years or PhD 2–4+ years) in pharma/managed care/consulting; collaboration with field and/or Market Access.
- Experience with real-world data sources/vendors (claims, EHR, registries) and translating findings into insights/value messages.
- Ability to influence without authority; drive decisions to closure.
- Strategic execution across 1–2 concurrent asset workstreams.
- Project/vendor management with scope, success criteria, budgets/timelines, risk mitigation.
- Congress strategy/publication planning experience.
Work arrangement:
- Hybrid; US-based; travel as needed.
- Evidence strategy and planning: Develop US RWE/HO evidence generation plan and design multiple studies aligned to US medical, payer, and access needs; translate strategy into workplans, timelines, and resourcing; develop study concepts, protocols, and innovative, cost-effective study approaches.
- Study leadership (RWE/HEOR): Lead day-to-day real-world evidence and health outcomes studies (e.g., RWE studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, patient-focused outcomes) with internal teams and external vendors.
- Stakeholder management: Provide periodic reporting to TA aligned business leaders; lead cross-functional meetings to align on evidence gaps and priorities; build relationships across Medical, Market Access, R&D, and Commercial.
- Scientific communication and quality: Draft/review specifications, protocols, statistical analysis plans, reports, abstracts, posters, manuscripts; ensure SOP adherence and high scientific/operational quality.
- Internal decision support: Provide RWE/HO input for development and commercialization planning (trial design, data gap assessments, value messages, evidence prioritization).
- External insight generation: Partner with Field Based Payer Medical Teams and field stakeholders; incorporate insights into evidence plans.
- Vendor and budget management: Manage scope, timelines, budgets, and change control; proactively escalate risks/issues.
- Governance/compliance/capability building: Complete required training and adhere to SOPs; improve processes for RWE/HO deliverables.
Required qualifications:
- Master’s or PhD in health economics/outcomes research, epidemiology, public health, biostatistics, or related.
- 3+ years pharma industry or academia research with US Oncology experience.
- Publication plan experience; RWE/HO study presence at major clinical congresses.
- Experience managing multiple projects simultaneously.
- Expertise in RWE and economic evaluation methods (publications; concept sheets/protocol contributions; bias/confounding mitigation; SAP/report contributions; publication/disclosure readiness).
- Strong communication/presentation skills.
- Proven ability to prioritize and manage in a matrix environment.
Preferred qualifications:
- Demonstrated success delivering health outcomes research outputs.
- Oncology experience (US/global) and familiarity with evolving standards/evidence needs.
- Advanced experience (Master’s 4–6 years or PhD 2–4+ years) in pharma/managed care/consulting; collaboration with field and/or Market Access.
- Experience with real-world data sources/vendors (claims, EHR, registries) and translating findings into insights/value messages.
- Ability to influence without authority; drive decisions to closure.
- Strategic execution across 1–2 concurrent asset workstreams.
- Project/vendor management with scope, success criteria, budgets/timelines, risk mitigation.
- Congress strategy/publication planning experience.
Work arrangement:
- Hybrid; US-based; travel as needed.